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ABSTRACT 
Glutamatergic dysfunction has been suggested to play an important role in the pathogenesis of 
hepatic encephalopathy (HE) in acute liver failure (ALF). Increased extracellular brain 
glutamate concentrations have consistently been described in different experimental animal 
models of ALF and in patients with increased intracranial pressure due to ALF. High brain 
ammonia levels remain the leading candidate in the pathogenesis of HE in ALF and studies have 
demonstrated a correlation between ammonia and increased concentrations of extracellular 
brain glutamate both clinically and in experimental animal models of ALF. Inhibition of 
glutamate uptake or increased glutamate release from neurons and/or astrocytes could cause 
an increase in extracellular glutamate. This review analyses the effect of ammonia on glutamate 
release from (and uptake into) both neurons and astrocytes and how these pathophysiological 
mechanisms may be involved in the pathogenesis of HE in ALF. 
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INTRODUCTION 
ACUTE LIVER FAILURE 
Acute liver failure (ALF) resulting from viral infections or toxic liver injury is a life-
threatening condition. Hepatic encephalopathy (HE) and brain edema are serious 
neurological complications of ALF, which must be treated promptly, ideally by a liver 
transplantation. HE in ALF progresses through altered mental status to stupor and coma 
within hours or days. Seizures and hyperexcitability are not uncommon. Mortality rates 
are high in ALF and death most frequently results from brainstem herniation due to 
increased intracranial pressure as a result of cytotoxic brain edema. The pathophysiologic 
mechanisms underlying the precise cause of HE and brain edema in ALF remain largely 
unknown. However, ammonia remains the leading candidate in the pathogenesis of ALF. 
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AMMONIA IN ALF 
Hyperammonemia is a consistent finding in experimental animal models of ALF resulting from 
hepatectomy, hepatic devascularization, or toxic liver injury, and in all cases, severe HE and 
brain edema are observed. A positive correlation has been reported between arterial ammonia 
concentrations and the appearance of brainstem herniation in patients with ALF (Clemmensen 
et al., 1999). In experimental animal models of ALF, brain ammonia levels may reach 
concentrations as high as 5 mM (Swain et al., 1992a), concentrations known to result in 
deleterious effects, by both direct and indirect mechanisms, on cerebral metabolism and 
neurotransmission. The importance of ammonia in ALF is emphasized and demonstrated in 
studies where ammonia-lowering strategies were shown to be beneficial in the prevention 
of brain edema and severe HE in rats with ALF (Cordoba et al., 1999; Rose et al., 1999, 
2000). In the present review article, “ammonia” will be used to represent the sum of 
ammonium ions (NH4) and ammonia (NH3) unless a distinction is made. 
THE GLUTAMATE SYSTEM 
GLUTAMATE RELEASE AND UPTAKE 
Glutamate is the principle excitatory neurotransmitter in the brain. Figure 1 demon-strates a 
simplified schematic representation of the steps that occur at the glutamate synapse. Glutamate 
is synthesized in the presynaptic nerve terminal via the enzyme glutaminase and stored in 
synaptic vesicles, which eventually dock with the presynaptic neuronal membrane and release 
glutamate into the synaptic cleft by a calcium-dependent mechanism. Released glutamate binds 
to and activates receptors (ionotropic and metabotropic) both on the postsynaptic neuron and 
the neighboring astrocyte. Situated on the postsynaptic neuron are ionotropic receptors: N-
methyl-D-aspartate (NMDA), a-amino-3-hydro-methyl-4-isoxasole-propionic acid (AMPA) and 
kainate, all ion channel-gated receptors. Also on the postsynaptic neuron are metabotropic 
receptors, which are not ion-gated receptors but are instead coupled to calcium dependent 
second messenger systems. On the neighboring astrocyte, AMPA, kainate, and metabotropic 
receptors are found. Released glutamate is removed from the extracellular space by high-
affinity Na 
+
-dependent transporters located both on astrocytes and neurons. GLT-1 and 
GLAST, more commonly referred to as, EAAT-2 and EAAT-1 respectively, are located on 
astrocytes. EAAT-3 is found on neurons, away from the presynaptic cleft and is, therefore, 
thought to play a minor role in glutamate clearance from the synaptic cleft. Glutamate uptake 
by astrocytes is an important pathway since ammonia removal in brain relies entirely from the 
synthesis of glutamine by the enzyme glutamine synthetase, found uniquely in astrocytes. The 
resulting glutamine produced is retransported to the presynaptic nerve terminal as the 
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INCREASED EXTRACELLULAR BRAIN GLUTAMATE IN ALF: EFFECT OF AMMONIA 
In recent years, the results of several studies have suggested that alterations in glutamatergic 
synaptic regulation are implicated in the pathogenesis of ALF. Using the technique in vivo 
cerebral microdialysis, several reports have consistently described increased extra-cellular 
concentrations of brain glutamate in different models of experimental ALF (Bosman et al., 
1992; de Knegt et al., 1994; Hilgier et al., 1999; Michalak et al., 1996). It has been suggested that 
ammonia (directly or indirectly) is causing this increase in extracellular brain glutamate 
concentrations. A positive correlation has been reported between extracellular brain 
concentrations of glutamate and arterial ammonia concentrations in acute (ischemic) liver 
failure in the rat (Michalak et al., 1996). Furthermore, using mild hypothermia as a treatment in 
rats with ALF, extracellular brain glutamate concentrations were normalized together with a 













Fig. 1. Keys steps involved at the glutamatergic synapse. Glutamate is released from the presynap-tic nerve 
terminal (PRE) into the synapse and stimulates glutamate receptors on the postsynaptic neuron (POST) or 
the neighboring astrocyte. Removal of glutamate occurs by high affinity astro-cytic glutamate transporters. 
Intracellular astrocytic glutamate stimulates the formation of glutamine by glutamine synthetase 2 and 
subsequently the elimination of ammonia. Astrocytic glutamine is shuttled to neurons to reform glutamate 
by the enzyme glutaminase 1 , completing the glutamate– glutamine cycle. Furthermore, stimulation of 
glutamate receptors on astrocytes results in an increase in intracellular calcium and subsequently a 
release of glutamate, possibly acting as a neuronal signal. 
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GLUTAMATERGIC DYSFUNCTION IN ALF 
Several studies have demonstrated glutamate receptor changes in brain of animals with ALF. 
[3H]-kainate binding sites were significantly reduced in cerebral cortical preparations from 
galactosamine-treated rabbits with severe encephalopathy (Ferenci et al., 1984). Similar 
findings of a significant loss of [ 3H]-kainate binding sites were subsequently reported in 
frontal cortex in ischemic liver failure in the rat (Michalak and Butterworth, 1997). In contrast, 
densities of neuronally localized NMDA binding sites are unchanged in ischemic liver 
failure in both rabbits (de Knegt et al., 1993) and rats (Michalak et al., 1996). Fur-
thermore, a selective loss of AMPA receptor binding sites was found in the brains of rats 
with ischemic liver failure (Michalak and Butterworth, 1997). This selective loss of AMPA 
sites could be the consequence of exposure of the brains of these animals to increased 
ammonia concentrations generated in ALF. In support of this possibility, previous studies 
have demonstrated a selective depression of AMPA currents by exposure of hippocampal 
pyramidal neurons to 3 mM ammonia (Fan and Szerb, 1993). In a separate series of 
electro-physiological studies, millimolar concentrations of ammonia led to a reduction in 
the degree of depolarization of cerebral cortical preparations by AMPA (Moroni et al., 
1995), suggesting that ammonia has the capacity to modify the structural or functional 
characteristics of the AMPA receptor. 
Therefore, increased extracellular glutamate in the brains of animals with HE in ALF, along 
with a concomitant loss of AMPA/kainate receptors could result in a relative increase of 
NMDA receptor-mediated transmission. In support of this theory, the noncompetitive 
NMDA receptor antagonist, memantine, administered to rats with liver ischemia resulted 
in significant improvement in clinical grading and less slowing of electroencephalogram 
activity (Vogels et al., 1997). These interesting findings support the notion that NMDA 
receptor activity is one of the characteristics of HE in experimental ALF. Furthermore, 
NMDA receptor activation has previously been shown to be increased in acute 
hyperammonemia in the absence of liver failure, and the NMDA receptor antagonist MK-
801 was found to afford significant protection in animals administered a lethal injection of 
ammonia (Marcaida et al., 1991). 
POSSIBLE REASONS FOR INCREASED EXTRACELLULAR BRAIN 
GLUTAMATE IN ALF 
GLUTAMATE RELEASE FROM NEURONS 
At physiological pH, more than 98% of ammonia is in NH4
+
 form, however NH3 enters cells 
more readily. The ammonium ion (NH4
+
) has an ionic radius very similar to K
+
 and has 
been suggested to enter cells through K
+
 channels. Therefore adding NH4
+
 is equivalent to 
increasing [K
+
]e, which subsequently decreases the membrane potential which in turn can 
be blocked by Ba2
+
, a potassium channel inhibitor. In neurons, ammonia (4 mM) has been 
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demonstrated to lower the membrane potential without altering membrane resistance. 
This suggests that metabolic factors rather than ion-conductance changes underlie the 
depolarization. A probable mechanism for the ammonium ion-induced depolarization is 
the loss of intracellular K
+





, which by reducing the equilibrium potential of K
+
 produces de-
polarization without altering membrane conductance. However, ammonium ions decrease 
synaptic transmission mediated by hyperpolarizing Cl
-
-dependent inhibitory postsynaptic 
potentials, an effect which results from the inactivation of the extrusion of Cl- from 
neurons (Raabe, 1989). Furthermore, ammonium ions depress excitatory synaptic trans-
mission in neurons (Szerb and Butterworth, 1992). It has been suggested that this 
depression of excitatory transmission by ammonium ions could be due to less glutamate 
available presynaptically for release. Glutaminase, found in neurons, produces glutamate 
plus ammonia from glutamine and subsequently ammonia has shown to inhibit 
glutaminase (Bradford et al., 1989). In addition, brain glutamate concentrations are 
reduced in rats with either acute (ischemic) liver failure or thioacetamide-induced liver 
damage (Swain et al., 1992b). Furthermore, postsynaptically, ammonia reduces the 
effectiveness of released glutamate (Fan et al., 1990) through AMPA receptors. Hamberger 
et al. demonstrated the inhibitory effect of ammonia on glutamate release as 3–5 mM 
NH4Cl reduced potassium evoked glutamate release from hippocampal slices (Hamberger 
et al., 1979, 1982). However, reviewing Fig. 1 from Hamburger et al. (1982) upon initial 
ammonia application (3 mM), an increase in glutamate release is demonstrated when 
compared with controls. Therefore, pretreatment with ammonia may reduce potassium 
stimulated glutamate release. However, glutamate is released in hippocampal slices upon 
an acute application of ammonia. Overall, ammonia inhibits glutamate synaptic 
transmission in neurons by (1) inhibiting current gated AMPA receptors postsynaptically 
and (2) depleting synaptically released glutamate from neurons by inhibiting the 
glutamate-producing enzyme, glutaminase. 
INHIBITION OF GLUTAMATE UPTAKE 
A great deal of evidence suggests that the increased extracellular brain glutamate in ALF results 
from an inhibition of glutamate uptake. Exposure of rat hippocampal slices to blood extracts 
from patients with varying severity of HE resulted in inhibition of D-aspartate uptake and the 
relative potency of inhibition was found to correlate with ammonia concentrations of the 
extracts (Schmidt et al., 1990). Decreased glutamate uptake was described in synaptosomal 
preparations from rats with experimental ALF (Oppong et al., 1995). Furthermore, exposure of 
primary cultured astrocytes to millimolar concentrations of ammonia also resulted in a 
significant reduction in uptake of [ 3H]-D-aspartate (Bender and Norenberg, 1996). In extracts 
from cerebral cortex of rats in coma stages of encephalopa-thy following hepatic 
devascularization, a significant loss of GLT-1 (EAAT-2) protein and gene expression was 
observed (Knecht et al., 1997). Similar findings were found in the brains of mice with 
thioacetamide-induced ALF (Norenberg et al., 1997). Recently, it has been shown that ammonia 
in concentrations equivalent to those reported in brain of ALF (5 mM), when added to cultured 
rat cortical astrocytes for 7 days, results in a comparative loss of glutamate uptake and in 
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addition loss of glutamate transporter GLAST (EAAT-1) protein and mRNA (Chan et al., 2000). 
Interestingly, EAAT-2 knockout mice manifest brain edema (Tanaka et al., 1997). Moreover, 
decreased astrocytic uptake of glutamate could limit ammonia detoxification by brain by 
limiting the availability of the substrate for glutamine synthetase. In ALF, the temporal 
development of brain edema is undefined and it is un-certain whether increased extracellular 
brain glutamate is a cause or an effect of astrocytic swelling. However, it has been 
demonstrated that a significant increase in extracellular glutamate arises before the 
development of brain edema (Michalak et al., 1996). It is ironic that glutamate uptake is 
inhibited in astrocytes during high toxic ammonia concentrations when glutamate is an 
important and necessary precursor for glutamine synthetase—the only ammonia removal 
system in the brain. Recently, Mort et al. (2001) demonstrated that an acute application of 
ammonia potentiates glutamate uptake in glial cells isolated from salamander retina, 
suggesting glutamate uptake inhibition may be a later phenomenon in the pathogenesis of HE 
and brain edema in ALF. 
GLUTAMATE RELEASE FROM ASTROCYTES 
Glutamate can be released from astrocytes by three different mechanisms: two by calcium-
independent (reverse glutamate transporter and swelling induced) and one by calcium-
dependent mechanisms (vesicular release). The role of ammonia in each of these 
glutamate release pathways is reviewed hereafter. 
CALCIUM-INDEPENDENT GLUTAMATE RELEASE 
Astrocytic Cell Swelling in ALF.  As mentioned previously, brain edema leading to increased 
intracranial pressure is a fatal consequence of ALF. It has been suggested that ammonia plays 
an important role in the pathogenesis of brain edema (astrocytic swelling) in ALF. Increased 
brain water content has been described in both normal (Takahashi et al., 1991) and in 
portacaval shunted (Blei et al., 1994) rats infused with ammonia as well as in rats with liver 
devascularization (Rose et al., 1999). Similar results have been described in vitro following the 
exposure of cultured astrocytes to ammonia (Norenberg et al., 1991). Furthermore, prevention 
of brain edema in rats with ALF has been shown with ammonia-lowering strategies (Cordoba et 
al., 1999; Rose et al., 1999, 2000). Unrelated to ammonia, swelling-induced glutamate release 
was demonstrated in cortical astrocytes exposed to a hypo-osmotic medium (Kimelberg et al., 
1990). Ammonia-induced astrocytic swelling has been suggested to result in glutamine 
accumulation in astrocytes (by glutamine synthetase), possibly because of the inhibition of 
glutaminase (Bradford et al., 1989). However, an increase in extracellular brain glutamate 
could also lead to glutamate-induced astroglial swelling (Hansson et al., 1997). 
Reversed Glutamate Transport. It has been demonstrated that when insufficient energy is 
available to regulate the membrane potential, glutamate transporters reverse, that is, glutamate 
transported out of the astrocyte instead of being transported in (Szatkowski et al., 1990). A fall 




 pump and therefore a rundown of the 




], and voltage. To re-establish the ion and voltage 
gradients, the glutamate transporters release glutamate, which occurs with the same 
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stoichiometry as forward uptake (i.e., 2 Na
+
 and 1 glutamate anion come out of the cell and 1 K
+
 
is transported into the cell). An increase in energy demand occurs upon ammonia application 
by stimulating glycolysis through activation of phosphofructokinase (Sugden and Newsholme, 
1975), and therefore possibly resulting in the stimulation of cerebral glucose utilization in 
acutely hyperammonemic animals (Hawkins et al., 1973). However, applications of NMR 
spectroscopy studies in rats with hyperammonemia due to ALF could not demonstrate any 
significant loss of ATP (Bates et al., 1989). Recently, much evidence has emerged suggesting an 
inhibition or slow down of energy metabolism in ALF. Ammonia chloride (5 mM) when applied 
to cultured astrocytes stimulates lactate production and lactate dehydrogenase activity 
(Bélanger et al., 2001). Similar results have been found in CSF of rats at precoma and coma 
stages with ALF (Chatauret et al., 2001). Clinically, using in vivo microdialysis techniques, 
extracellular lactate was found to increase in association with increased intracranial 
pressure in patients with ALF (Tofteng et al., 2001). Increase in lactate production 
indirectly suggests that anaerobic pathways may be stimulated to compensate for a 
decreased pyruvate oxidation (possibly because of the ammonia inhibition on the enzyme 
α-ketoglutarate dehydrogenase in the tricarboxylic acid cycle (Lai and Cooper, 1986)). 
However, acute ammonia exposure did not reverse glutamate transporters but increased 
glutamate uptake into astrocytes (Mort et al., 2001), suggesting that glutamate transporter 
reversal is not the cause of the initial increase in extracellular glutamate. 
Calcium-Dependent Glutamate Release The role of astrocytes in synaptic transmission is 
an important new concept for nor-mal brain function. It was originally thought that astrocytes 
were unresponsive to excita-tory neurotransmitters and only neurons could respond with 
depolarization and excitation. However, in a recent review (Vesce et al., 2001), the active role of 
astrocytes in synaptic transmission and its importance in neuron-glia signaling is described. 
Glutamate released from neurons can bind to its respective receptors (AMPA/kainate and 
metabotropic) on the astrocyte and trigger [Ca2
+
]i elevation. Interestingly, astrocytes possess 
vesicular proteins (e.g. SNARE complex) which are essential in vesicular neurotransmitter 
release (Araque et al., 2000). This raises the strong possibility that astrocytes can release 
glutamate by Ca2
+
-dependent mechanisms. It was subsequently demonstrated that glutamate 
binding to its receptors on astrocytes triggers a [Ca2
+
]i response and stimulates glutamate 
release. However, glutamate release is not specific to glutamate binding. Other studies have 
shown glutamate can be released upon triggering [Ca2
+
]i with bradykinin (Papura et al., 1994), 
KCl (Nicholls and Sihra, 1986), or more recently ATP (Innocenti et al., 2000; Jeremic et al., 
2001). Furthermore, Pasti et al. (2001) demonstrated that increased cytosolic calcium regulates 
exocytotic release of glutamate. More specifically, it was further demonstrated that Ca2
+
-
dependent release of glutamate was mediated by prostaglandins because cyclooxy-genase 
inhibitors potently inhibited glutamate release (Bezzi et al., 1998). Lipoxygenase and 
epoxygenase inhibitors were ineffective and furthermore cyclooxygenase metabolites 
(prostaglandins) PGD2, PGE2, and PGF2a, all induced rapid glutamate release with PGE2 
being the most effective. 
Ammonium chloride at concentrations of 5, 10, and 20 mM has been shown to de-polarize 
cultured rat cortical astrocytes and that the sustained depolarization induced by ammonia 
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depended on changes in intracellular ion concentrations rather than changes in ion 
conductances. Also, ammonia at 5 mM stimulates an increase in [Ca2
+
]i in cultured astrocytes, 
using calcium-imaging techniques (Rose and Kettenmann, unpublished data). Calcium can 
increase intracellularly by entering the cell from the extracellular space through Ca2
+
 voltage-
gated channels and/or specific pumps and transporters or can be released from internal stores. 
Ammonia depolarizes astrocytes and at very high concentrations can open voltage-gated 
calcium channels when the membrane potential is raised sufficiently high. In addition, 
ammonia releases calcium from IP3-sensitive intracellular calcium stores in microglia (Minelli 
et al., 2000). This has raised the possibility that ammonia can stimulate glutamate release from 




Increased extracellular concentrations of brain glutamate in ALF can result from an in-crease in 
glutamate release and/or a decrease in glutamate removal (uptake) both by neurons and/or 
astrocytes. Glutamate can be released from neurons and astrocytes by cell swelling induced 
mechanisms, reversal of glutamate transporters, and/or calcium-dependent mechanisms. In 
neurons, an increase in glutamate release is unlikely to occur because ammonia inhibits 
glutaminase reducing the amount of glutamate available for synaptic release. Fur-thermore, 
cytotoxic edema in ALF develops in astrocytes and not neurons, eliminating the possibility of 
swelling-induced release of glutamate from neurons. An inhibition of glu-tamate removal by the 
high affinity transporters on astrocytes would result in an increase in extracellular brain 
glutamate concentrations. However, it has been demonstrated in vitro that acute application of 
ammonia potentiates glutamate uptake into astrocytes (Mort et al., 2001). Ammonia-induced 
astrocytic swelling may potentially stimulate glutamate release from astrocytes; however, this 
would suggest that increased extracellular brain glutamate is the result and not a cause of 
astrocytic swelling. Interestingly, increased extracellular brain glutamate concentrations 
precede the onset of brain edema in rats with ALF due to hepatic devascularization (Michalak 
et al., 1996). Reversal of glutamate transporters occurs when high-energy phosphates are 
depleted. Although ATP levels have been found to be unchanged in ALF, increased lactate 
production has been demonstrated, suggesting an inhibition of glucose oxidation but this 
appears to arise late in the development of HE in ALF. Astrocytes play an important role in 
synaptic transmission and under normal physiological conditions are capable of releasing 
glutamate in a calcium-dependent manner. 
There is now increasing evidence that ammonia can stimulate [Ca2
+
]i leading to stimulation 
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Figure 2. Diagram demonstrating the possible mechanisms involved in the development of HE and 
brain edema in ALF. 
occur during the development of HE and brain edema in ALF. Ammonia enters neurons and 
inhibits glutaminase resulting in (1) less glutamate produced and available for release and (2) 
disruption of the glutamate–glutamine cycle between astrocytes and neurons. Ammonia 
also inhibits AMPA receptor activation but does not affect NMDA receptors. Overall, 
ammonia decreases glutamate release from neurons by inhibiting synaptic transmission 
and decreasing intracellular glutamate. Ammonia also enters astrocytes and (1) is 
detoxified by glutamine synthetase producing glutamine and (2) stimulates glutamate 
release in a calcium-dependent manner leading to increased extracellular glutamate. With 
inhibition of the glutamate–glutamine cycle, glutamine remains “trapped” in the astrocyte 
resulting in intracellular hypertonicity and cytotoxic swelling. Deregulation of the release 
of glutamate from astrocytes could also be a factor involved in astrocytic swelling. Once 
the astrocyte is swollen, glutamate uptake is inhibited to decrease the ion uptake 
preventing further swelling. Furthermore, inhibition of glutamate uptake and swelling-
induced release of glutamate may add to the already increased extracellular 
concentrations of glutamate. Because NMDA receptors are not affected by ammonia as are 
the AMPA/kainate receptors, this may explain the seizures and hyperexcitability, not 
uncommonly seen in patients with ALF. 
 
 
Rose, C., 2002. Increased extracellular brain glutamate in acute liver failure: decreased uptake or 
increased release? Metabolic Brain Disease, 17(4), p.251–261.  
The final publication is available at http://dx.doi.org/10.1023/A:1021945515514 
ACKNOWLEDGMENTS 
Christopher Rose is a recipient of the Alexander von Humboldt fellowship and wishes to 
thank them for their support. 
REFERENCES 
Araque, A., Li, N., Doyle, R.T., and Haydon, P. (2000). Snare protein-dependent glutamate release 
from astrocytes.J. Neurosci. 20:666–673. 
Bates, T.E., Williams, S.R., Kauppinen, R.A., and Godian, D.G. (1989). Observation of cerebral 
metabolites in an animal model of acute liver failure in vivo: 1H and 31P nuclear magnetic resonance 
study. J. Neurochem. 53:102–110. 
Belanger, M., Chan, H., Hazell, A.S., and Butterworth, R.F. (2001). Increased lactate dehydrogenase 
(LDH) expression and activity in cultured astrocytes exposed to ammonia. J. Neurochem. 78(Suppl. 
1):25. 
Bender, A.S., and Norenberg, M.D. (1996). Effects of ammonia on L-glutamate uptake in cultured 
astrocytes.Neurochem. Res. 21:567–573. 
Bezzi, P., Carmignoto, G., Pasti, L., Vesce, S., Rossi, D., Rizzini, B.L., et al. (1998). Prostaglandins 
stimulate calcium-dependent glutamate release in astrocytes. Nature 391:281–285. 
Blei, A.T., Olafsson, S.M., Therrien, G., and Butterworth, R.F. (1994). Ammonia-induced cerebral 
edema and intracranial hypertension in rats after portacaval anastomosis. Hepatology 19:1431–
1444. 
Bosman, D.K., Deutz, N.E.P., Maas, M.A.W., van Eijk, H.M.H., Smit, J.J.H., de Hann, J.G., et al. (1992). 
Amino acid release from cerebral cortex in experimental acute liver failure, studied by in vivo 
cerebral cortex microdialysis. J. Neurochem. 59:591–599. 
Bradford, H.F., Ward, H.K., and Foley, P. (1989). Glutaminase inhibition and release of 
neurtransmitter glutamate from synaptosomes. Brain Res. 476:29–34. 
Chan, H., Hazell, A.S., Desjardins, P., and Butterworth, R.F. (2000). Effects of ammonia on glutamate 
transporter (GLAST) protein and mRNA in cultured rat cortical astrocytes. Neurochem. Int. 37:243–
248. 
Chatauret, N., Rose, C., Therrien, G., and Butterworth, R.F. (2001). Mild hypothermia prevents 
cerebral edema and CSF lactate accumulation in acute liver failure. Metab. Brain Dis. 16:95–102. 
Clemmensen, J.O., Larsen, F.S., Kondrup, J., Hansen, B.A., and Ott, P. (1999). Cerebral herniation in 
patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 
29:648–653. 
Cordoba, J., Crespin, J., Gottstein, J., and Blei, A.T. (1999). Mild hypothermia modifies ammonia-
induced brain edema in rats after portacaval anastomosis. Gastroenterology 116:686–693. 
Rose, C., 2002. Increased extracellular brain glutamate in acute liver failure: decreased uptake or 
increased release? Metabolic Brain Disease, 17(4), p.251–261.  
The final publication is available at http://dx.doi.org/10.1023/A:1021945515514 
de Knegt, R.J., Kornhuber, J., Schalm, S.W., Rusche, K., Riederer, P., and Tan, J. (1993). Binding of the 
lig-and [3H]MK-801 to the MK-801 binding site of the N-methyl-D-aspartate receptor during 
experimental encephalopathy from acute liver failure and from acute hyperammonemia in the 
rabbit. Metab. Brain Dis. 8:81–94. 
de Knegt, R.J., Schalm, S.W., van der Rijt, C.C.D., Fekkes, D., Dalm, E., and Hekking-Weyma, I. (1994). 
Extra-cellular brain glutamate during acute liver failure and during acute hyperammonemia 
simulating acute liver failure: An experimental study based on in vivo brain dialysis. J. Hepatol. 
20:19–26. 
Fan, P., Lavoie, J., L´e, N.L.O., Szerb, J.C., and Butterworth, R.F. (1990). Neurochemical and 
electrophysiological studies on the inhibitory effect of ammonium ions on synaptic transmission in 
slices of rat hippocampus: Evidence for a postsynaptic action. Neuroscience 37:327–334. 
Fan, P., and Szerb, J.C. (1993). Effects of ammonium ions on synaptic transmission and on responses 
to quisqualate and N-methyl-D-aspartate in hippocampal CA1 pyramidal neurons in vitro. Brain Res. 
632:225–231. 
Ferenci, P., Pappas, S.C., Munson, P.J., Henson, K., and Jones, E.A. (1984). Changes in the status of 
neurotrans-mitter receptors in a rabbit model of hepatic encephalopathy. Hepatology 4:186–191. 
Hamberger, A., Hedquist, B., and Nystrom, B. (1979). Ammonium ion inhibition of evoked release of 
endogenous glutamate from hippocampal slices. J. Neurochem. 33:1295–1302. 
Hamberger, A., Lindroth, P., and Nystrom, B. (1982). Regulation of glutamate biosynthesis and 
release in vitro by low levels of ammonium ions. Brain Res. 237:339–350. 
Hansson, E., Blomstrand, F., Khabiti, S., Olsson, T., and R¨onnback, L. (1997). Glutamate induced 
astroglial swelling-methods and mechanisms. Acta Neurochir. 70:148–151. 
Hawkins, R.A., Miller, A.L., Nielsen, R.C., and Veech, R.L. (1973). The acute action of ammonia on rat 
brain metabolism in vivo. Biochem. J. 134:1001–1008. 
Hilgier, W., Zielinska, M., Borkowska, H.D., Gadamski, R., Walski, M., Oja, S.S., et al. (1999). Changes in 
the extracellular profiles of neuroactive amino acids in the rat striatum at the symptomatic stage of 
hepatic failure.J. Neurosci. Res. 56:76–84. 
Innocenti, B., Parpura, V., and Haydon, P.G. (2000). Imaging extracellular waves of glutamate during 
calcium signalling in cultured astrocytes. J. Neurosci. 20:1800–1808. 
Jeremic, A., Jeftinija, K., Stevanovic, J., Glavaski, A., and Jeftinija, S. (2001). ATP stimulates calcium-
dependent glutamate release from cultured astrocytes. J. Neurochem. 77:664–675. 
Kimelberg, H.K., Goderie, S.K., Higman, S., Pang, S., and Waniewski, R.A. (1990). Swelling-induced 
release of glutamate, aspartate and taurine from astrocyte culture. J. Neurosci. 10:1583–1591. 
Knecht, K., Michalak, A., Rose, C., Rothstein, J.D., and Butterworth, R.F. (1997). Decreased glutamate 
transporter (GLT-1) expression in frontal cortex of rats with acute liver failure. Neurosci. Lett. 
229:201–203. 
Rose, C., 2002. Increased extracellular brain glutamate in acute liver failure: decreased uptake or 
increased release? Metabolic Brain Disease, 17(4), p.251–261.  
The final publication is available at http://dx.doi.org/10.1023/A:1021945515514 
Lai, J.C.K., and Cooper, A.J.L. (1986). Brain Æ-ketoglutarate dehydrogenase complex: Kinetic 
properties, regional distribution and effects of inhibitors. J. Neurochem. 47:1376–1386. 
Marcaida, G., Felipo, V., Hermenegildo, C., Minana, M.-D., and Grisolia, S. (1992). Acute ammonia 
toxicity is mediated by the NMDA type of glutamate receptors. FEBS Lett. 296:67–68. 
Michalak, A., and Butterworth, R.F. (1997). Selective loss of binding sites for the non-NMDA 
(glutamate) receptor ligands [3H]-kainate and (S)-[3H]-5-fluorowillardiine in the brains of rats with 
acute liver failure. Hepatology 25:631–635. 
Michalak, A., Rose, C., Butterworth, J., and Butterworth, R.F. (1996). Neuroactive amino acides and 
gluta-mate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure. 
Hepatology 24:908– 914. 
Minelli, A., Lyons, S., Nolte, C., Verkhratsky, A., and Kettenmann, H. (2000). Ammonium triggers 
calcium elevation in cultured mouse astroglial cells by initiating Ca2C release from thapsigargin-
densitive intracellular stores. Eur. J. Physiol. 439:370–377. 
Moroni, F., Mannaioni, G., Cherici, G., Leonardi, P., Carla, V., and Lombardi, G. (1995). Excitatory 
amino acid neurotransmission and ammonia toxicity. In: Capocaccia, L., Merli, M., and Riggio, O. 
(eds.), Advances in Hepatic Encephalopathy and Metabolic Nitrogen Exchange, CRC Press, Boca 
Raton, FL, Chap. 22, pp. 130–139. 
Mort, D., Marcaggi, P., Grant, J., and Attwell, D. (2001). Effect of acute exposure to ammonia on 
glutamate transport in glial cells isolated from the salamander retina. J. Neurophysiol. 86:836–844. 
Nicholls, D.G., and Sihra, T.S. (1986). Synaptosomes possess an exocytotic pool of glutamate. Nature 
321:772– 773. 
Norenberg, M.D., Baker, L., Norenberg, L.O.B., Blicharska, J., Bruce-Gregario, H.H., and Neary, J.T. 
(1991). Ammonia-induced astrocyte swelling in primary culture. Neurochem. Res. 16:833–836. 
Norenberg, M.D., Huo, Z., Neary, J.T., and Roig-Cantesano, A. (1997). The glial glutamate transporter 
in hyperam-monemia and hepatic encephalopathy: Relation to energy metabolism and glutamatergic 
neurotransmission. Glia 21:124–133. 
Oppong, K.N.W., Bartlett, K., Record, C.O., and Al Mardini, H. (1995). Synaptosomal glutamate 
transport in thioacetamide-induced hepatic encephalopathy. Hepatology 22:553–558.Papura, V., 
Basarsky, T.A., Liu, F., Jeftinija, K., Jeftinija, S., and Haydon, P.G. (1994). Glutamate-mediated 
astrocyte-neuron signalling. Nature 369:744–749. 
Pasti, L., Zonta, M., Pozzan, T., Vicini, S., and Carmignoto, G. (2001). Cytosolic calcium oscillations in 
astrocytes may regulate exocytotic release of glutamate. J. Neurosci. 21:477–484. 
Raabe, W. (1989). Ammonium decreases excitatory synaptic transmission in cat spinal cord in vivo. J. 
Neurophysiol. 62:1461–1473. 
Rose, C., Michalak, A., Rama Rao, K.V., Quack, G., Kircheis, G., and Butterworth, R.F. (1999). L-
ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in 
rats with acute liver failure. Hepatology 30:636–640. 
Rose, C., 2002. Increased extracellular brain glutamate in acute liver failure: decreased uptake or 
increased release? Metabolic Brain Disease, 17(4), p.251–261.  
The final publication is available at http://dx.doi.org/10.1023/A:1021945515514 
Rose, C., Michalak, A., Rambaldi, A., Chatauret, N., Pannunzio, M., and Butterworth, R.F. (2000). Mild 
hypother-mia delays the onset of coma and prevents brain edema and extracellular brain glutamate 
accumulation in rats with acute liver failure. Hepatology 31:872–877. 
Schmidt, W., Wolf, G., Grungreiff, K., Meier, M., and Reum, T. (1990). Hepatic encephalopathy 
influences high-affinity uptake of transmitter glutamate and aspartate into the hippocampal 
formation. Metab. Brain Dis. 5:19–31. 
Sugden, P.H., and Newsholme, E.A. (1975). The effects of ammonium, inorganic phosphate and 
potassium ions on the activity of phosphofructokinases from muscle and nervous tissues of 
vertebrates and invertebrates.Biochem. J. 150:113–122. 
Swain, M., Butterworth, R.F., and Blei, A.T. (1992a). Ammonia and related amino acids in the 
pathogenesis of brain edema in acute liver failure in rats. Hepatology 15:449–453. 
Swain, M., Bergeron, M., Audet, R., Blei, A.T., and Butterworth, R.F. (1992b). Monitoring of 
neurotransmitter amino acids by means of indwelling cisterna magna catheter: A comparison of two 
rodent models of fulminant hepatic failure. Hepatology 16:1028–1035. 
Szatkowski, M., Barbour, B., and Attwell, D. (1990). Nonvesicular release of glutamate from glial cells 
by reversed electrogenicglutamate uptake. Nature 348:443–446. 
Szerb, J.C., and Butterworth, R.F. (1992). Effect of ammonium ions on synaptic transmission in the 
mammalian nervous system. Prog. Neurobiol. 39:135–153. 
Takahashi, H., Koehler, R.C., Brusilow, S.W., and Traystman, R.J. (1991). Inhibition of brain glutamine 
accumu-lation prevents cerebral edema in hyperammonemic rats. Am. J. Physiol. 281:H825–H829. 
Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., et al. (1997). Epilepsy 
and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 
276:1699–1702. 
Tofteng, F., Jorgensen, L., Ansen, B.A., Ott, P., Kondrup, J., and Larsen, F. (2001). Cerebral 
microdialysis of glutamate and lactate in patients with fulminant hepatic failure. Hepatology 
34:658A. (Abstract No. 1943.) 
Vesce, S., Bezzi, P., and Volterra, A. (2001). Synaptic transmission with the glia. News Physiol. Sci. 
16:178–184. Vogels, B.A.P., Maas, M.A.W., Daalhuisen, J., Quack, G., and Chamuleau, R.A.F.M. (1997). 
Memantine, a non-competitive NMDA-receptor antagonist improves hyperammonemia-induced 
encephalopathy and acute hep-atic encephalopathy in rats. Hepatology 25:820–827. 
 
